Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Anti-Infectives Knowledge Network (AIKN) IFI Updates

    Regularly updated with the latest evidence on invasive fungal infections, the most recent
    update to be added to the AIKN-IFI summarises the findings from a consensus of
    international experts on the management of intra-abdominal candidiasis.

    Healthcare professionals can view the recommendations for free; it can be found in the
    guidelines section of this resource.

    March 2015 MYC/15/0019/EUa

  • ,

    Anti-Infectives Knowledge Network (AIKN) CDI Updates

    Recently updated with ISICEM 2015 presentations, data from the largest ever European
    clinician consensus report, as well as key perspectives on Clostridium difficile infection
    The Anti-Infectives Knowledge Network shares expertise and experience in the area of

    This educational resource is an initiative by Astellas Pharma EMEA. Please remember
    to return often to read the news, clinical insights, and essential information from the
    latest anti-infectives congresses.

    March 2015 FDX/15/0024/EUb

  • ,

    New Therapy Focus area for
    type 2 diabetes launched

    This free resource has recently launched on epgonline.org containing information
    for healthcare professionals based in Europe on the use of incretin‐insulin treatment
    combinations for type 2 diabetes. Explore five informative sections focused on the role
    emerging incretin‐based therapies can play in the long‐term treatment and management of
    type 2 diabetes.

  • ,Whats's New Diabetes Knowledge Centre Relaunch

    Updated Type 2 Diabetes Mellitus Knowledge Centre

    Explore new information added to the diagnosis and treatment sections of the
    Type 2 Diabetes Mellitus Knowledge Centre with recommendations on the appropriate
    management of the condition. A brand new guidelines section is also available,
    containing the latest recommendations from ADA, EASD and NICE.

  • ,What's New Hypogonadism

    Hypogonadism Knowledge Centre

    epgonline.org’s Hypogonadism Knowledge Centre features a publications digest section,
    regularly updated with analysis and comment on recent scientific articles related to male

    Found within the Men’s Health/Andrology disease topic homepage, users can also access
    information on the prevalence, diagnosis and available treatment options for male

Latest News

Success for Dalvance (dalbavancin) in DUR 001-303 Study for ABSSSI- Actavis


DUR 001-303 Study Meets Primary & Secondary Endpoints--- Actavis plc has announced positive top-line results for study DUR001-303, a phase III study comparing a single 1500 mg dose of Dalvance with the same total dose given as two-doses one week ...

CHMP recommends Lixiana (edoxaban) for non-valvular AF, and deep vein thrombosis and pulmonary embolism-Daiichi Sankyo


The EU's CHMP has recommended approval of Lixiana (edoxaban), from Daiichi Sankyo, for the prevention of stroke and systemic embolism (SE) in adult patients with non-valvular atrial fibrillation (NVAF) with one or more risk factors. The CHMP also ...

Positive data from STAR study of NanoKnife system in Pancreatic Cancer-AngioDynamics


Results from the Soft Tissue Ablation Registry (STAR), demonstrate that irreversible electroporation (IRE) with the NanoKnife System, from AngioDynamics, in combination with standard chemotherapy, doubled the overall survival rate of locally advanced ...

Positive results from BOSON Phase III study with Sovaldi (sofosbuvir) in HCV-Gilead


Gilead Sciences has announced results from the BOSON Phase III study evaluating the safety and efficacy of Sovaldi (sofosbuvir 400 mg) in combination with ribavirin (RBV) or with pegylated interferon (PEG)/RBV which demonstrated high cure rates ...

Phase III trial of MD 1003 meets primary endpoint in Multiple Sclerosis-MedDay


MedDay has announced positive results from the pivotal Phase III clinical trial, MS-SPI demonstrating the efficacy and safety of MD 1003 (biotin) in the treatment of primary and secondary progressive multiple sclerosis. The primary endpoint was met ...

AstraZeneca, MedImmune and Celgene collaborate on development and commercialisation of MEDI4736 in blood cancers.


AstraZeneca and MedImmune, the Company’s global biologics research and development arm, announced that they have entered into an exclusive collaboration agreement with Celgene Corporation, a global leader in haematological cancers, for the ...

AstraZeneca,MedImmune and Innate Pharma to combine MEDI4736 and IPH 2201 in cancer treatments.


AstraZeneca and MedImmune, the Company’s global biologics research and development arm, announced that they have entered into a collaboration to accelerate and broaden the development of Innate Pharma SA’s proprietary anti-NKG2A antibody, IPH 2201, ...

Recent Updates


Clinical Guidelines

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis


EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice

Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Medical Journals

Identification of an anti-inflammatory derivative with anti-cancer potential: The impact of each of its structural components on inflammatory responses in macrophages and bladder cancer cells.

Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer

Liraglutide and obesity: a review of the data so far.

MAP Kinase Phosphatase 2 Regulates Macrophage-Adipocyte Interaction.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages



News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors